Evaluation of protective effects of methylene blue on cisplatin-induced nephrotoxicity
Authors:
Open Access
- 25 April 2022
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 150, 113023
Abstract
No abstract availableKeywords
Funding Information
- Bu-Ali Sina University
This publication has 41 references indexed in Scilit:
- Transforming growth factor- and the progression of renal diseaseNephrology Dialysis Transplantation, 2013
- From methylene blue to chloroquine: a brief review of the development of an antimalarial therapyParasitology Research, 2012
- Mechanisms of Cisplatin NephrotoxicityToxins, 2010
- Revisiting the Association of Cationic Groove-Binding Drugs to DNA Using a Poisson-Boltzmann ApproachBiophysical Journal, 2010
- Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled TrialPLOS ONE, 2009
- Ghrelin Prevents Cisplatin-Induced Mechanical Hyperalgesia and CachexiaEndocrinology, 2007
- Antidote Use in the Critically Ill Poisoned PatientJournal of Intensive Care Medicine, 2006
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Naringenin attenuates cisplatin nephrotoxicity in ratsLife Sciences, 2005
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003